Navigating Uncertainty in Gene Therapy

This chapter dives into the excitement and mixed sentiments surrounding recent conferences like ASCO and the American Society of Cell and Gene Therapy in New Orleans. With Jason Mast sharing insights, the hosts explore the challenges of gene editing amidst political and funding concerns, highlighting a hopeful case of successful custom gene therapy for a young patient. The conversation also discusses significant developments in regulatory practices and the evolving biotech landscape as companies adapt to contemporary challenges.